Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial

F.R. Mauro; A.M. Carella; S. Molica; F. Paoloni; A.M. Liberati; F. Zaja; V. Belsito; A. Cortellezzi; R. Rizzi; P. Tosi; M. Spriano; A. Ferretti; M. Nanni; M. Marinelli; M.S. De Propris; S.M. Orlando; M. Vignetti; A. Cuneo; A.R. Guarini; R. Foà

doi:10.1080/10428194.2016.1258698

Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial

F.R. Mauro, A.M. Carella, S. Molica, F. Paoloni, A.M. Liberati, F. Zaja, V. Belsito, A. Cortellezzi, R. Rizzi, P. Tosi, M. Spriano, A. Ferretti, M. Nanni, M. Marinelli, M.S. De Propris, S.M. Orlando, M. Vignetti, A. Cuneo, A.R. Guarini, R. Foà

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1640-1647
Number of pages	8
Journal	Leukemia and Lymphoma
Volume	58
Issue number	7
DOIs	https://doi.org/10.1080/10428194.2016.1258698
Publication status	Published - 2017

Access to Document

10.1080/10428194.2016.1258698

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84996836134&doi=10.1080%2f10428194.2016.1258698&partnerID=40&md5=062a484f86742774ca69d1b80ccbdbb3

Cite this

Mauro, F. R., Carella, A. M., Molica, S., Paoloni, F., Liberati, A. M., Zaja, F., Belsito, V., Cortellezzi, A., Rizzi, R., Tosi, P., Spriano, M., Ferretti, A., Nanni, M., Marinelli, M., De Propris, M. S., Orlando, S. M., Vignetti, M., Cuneo, A., Guarini, A. R., & Foà, R. (2017). Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial. Leukemia and Lymphoma, 58(7), 1640-1647. https://doi.org/10.1080/10428194.2016.1258698

Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial. / Mauro, F.R.; Carella, A.M.; Molica, S.; Paoloni, F.; Liberati, A.M.; Zaja, F.; Belsito, V.; Cortellezzi, A.; Rizzi, R.; Tosi, P.; Spriano, M.; Ferretti, A.; Nanni, M.; Marinelli, M.; De Propris, M.S.; Orlando, S.M.; Vignetti, M.; Cuneo, A.; Guarini, A.R.; Foà, R.

In: Leukemia and Lymphoma, Vol. 58, No. 7, 2017, p. 1640-1647.

Research output: Contribution to journal › Article › peer-review

Mauro, FR, Carella, AM, Molica, S, Paoloni, F, Liberati, AM, Zaja, F, Belsito, V, Cortellezzi, A, Rizzi, R, Tosi, P, Spriano, M, Ferretti, A, Nanni, M, Marinelli, M, De Propris, MS, Orlando, SM, Vignetti, M, Cuneo, A, Guarini, AR & Foà, R 2017, 'Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial', Leukemia and Lymphoma, vol. 58, no. 7, pp. 1640-1647. https://doi.org/10.1080/10428194.2016.1258698

Mauro, F.R. ; Carella, A.M. ; Molica, S. ; Paoloni, F. ; Liberati, A.M. ; Zaja, F. ; Belsito, V. ; Cortellezzi, A. ; Rizzi, R. ; Tosi, P. ; Spriano, M. ; Ferretti, A. ; Nanni, M. ; Marinelli, M. ; De Propris, M.S. ; Orlando, S.M. ; Vignetti, M. ; Cuneo, A. ; Guarini, A.R. ; Foà, R. / Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial. In: Leukemia and Lymphoma. 2017 ; Vol. 58, No. 7. pp. 1640-1647.

@article{f0782dae14ab4c1a83daad451858b891,

title = "Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial",

author = "F.R. Mauro and A.M. Carella and S. Molica and F. Paoloni and A.M. Liberati and F. Zaja and V. Belsito and A. Cortellezzi and R. Rizzi and P. Tosi and M. Spriano and A. Ferretti and M. Nanni and M. Marinelli and {De Propris}, M.S. and S.M. Orlando and M. Vignetti and A. Cuneo and A.R. Guarini and R. Fo{\`a}",

note = "Cited By :1 Export Date: 31 October 2017 CODEN: LELYE Correspondence Address: Mauro, F.R.; Department of Cellular Biotechnologies and Hematology, Hematology, Sapienza University, Via Benevento 6, Italy; email: mauro@bce.uniroma1.it",

year = "2017",

doi = "10.1080/10428194.2016.1258698",

language = "English",

volume = "58",

pages = "1640--1647",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "7",

}

TY - JOUR

T1 - Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial

AU - Mauro, F.R.

AU - Carella, A.M.

AU - Molica, S.

AU - Paoloni, F.

AU - Liberati, A.M.

AU - Zaja, F.

AU - Belsito, V.

AU - Cortellezzi, A.

AU - Rizzi, R.

AU - Tosi, P.

AU - Spriano, M.

AU - Ferretti, A.

AU - Nanni, M.

AU - Marinelli, M.

AU - De Propris, M.S.

AU - Orlando, S.M.

AU - Vignetti, M.

AU - Cuneo, A.

AU - Guarini, A.R.

AU - Foà, R.

N1 - Cited By :1 Export Date: 31 October 2017 CODEN: LELYE Correspondence Address: Mauro, F.R.; Department of Cellular Biotechnologies and Hematology, Hematology, Sapienza University, Via Benevento 6, Italy; email: mauro@bce.uniroma1.it

PY - 2017

Y1 - 2017

U2 - 10.1080/10428194.2016.1258698

DO - 10.1080/10428194.2016.1258698

M3 - Article

VL - 58

SP - 1640

EP - 1647

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 7

ER -